Feb 21, 2023

English - UK

Pramod Pawar

Global Bio-banking Market to Offer Numerous Opportunities at A CAGR of 6.3% through 2032

Introduction: 

A biobank is a bio-repository that holds biological samples for research. Biobanks are an important resource for medical research. They support many types of modern research like genomics, personalized medicine, and other related areas. Biobanks allow researchers to access data that is representative of a large population. Biobanks can be used by multiple researchers to collect data and provide access to samples. A Biobank is a place that stores, distributes and collects biological material of human beings. It can include plasma, purified DNA and blood, saliva, as well as other bio specimens.

Biobanks are used to keep records of patient's health and personal information. To store biological materials in biobanks, it is necessary to have the right environment. This information and specimens are used to identify the causes of diseases. Many diseases can be associated with single-nucleotide monomorphism. Each sample is registered and recorded in a central location. This can usually be done on a computer system that can be regularly backed up. The current systems can store nearly 40,000 samples in a fraction of the space needed by a freezer at 80 degrees Celsius. For security reasons, duplicate samples are often kept in a separate place.

Market Insight:

Global bio-banking market size is expected to be worth around USD 88.9 billion by 2032 from USD 48.9 billion in 2022, growing at a CAGR of 6.3% during the forecast period from 2022 to 2032.

Figure:

 

 Key Takeaways:

  • The global bio banking market is expected to grow significantly in the coming years. Factors driving this growth include increasing demand for personalized medicine, advancements in bio banking technologies, and rising awareness about the importance of preserving biological samples for research.
  • Biobanks play a critical role in the research and development of new treatments and therapies for a wide range of diseases, including cancer, cardiovascular disease, and neurological disorders.
  • The bio banking market is divided into two main types: human biobanking and non-human biobanking. Human biobanking accounts for the majority of the market share and is expected to continue to dominate the market in the coming years.
  • North America is currently the largest market for biobanking, followed by Europe and the Asia Pacific region. The Asia Pacific region is expected to be the fastest-growing market in the coming years, driven by increasing investments in biobanking infrastructure and rising demand for personalized medicine.

Get the sample pages of report@ https://market.us/report/biobanking-market/request-sample/

Regional Snapshot

Europe was the world's largest biobanking sector in 2020. The presence of many established biobanks is a hallmark of the Nordic countries. Global Engage also revealed that 40% of Icelanders had donated their DNA. It is stored in private biobanks. The European biobanking market is experiencing positive growth due to the growing volume of human biosamples. Europe's dominance in the global biobanking marketplace is due to the presence of many top pharmaceutical companies involved in drug discovery, clinical trials, as well the increased use of virtual biobanks.

Asia Pacific is forecast to see significant growth due to the presence several top research institutes and medical centers in countries such as India, China, and China. The Asia Pacific Biobanking Market is expected to rise due to increasing government investments in drug research and growing demand for precision medicine.

Key Trends:

  • Increasing adoption of personalized medicine and advancements in regenerative medicine are driving the growth of the bio-banking market.
  • The integration of biobanks with hospital information systems is leading to better data management and streamlined processes.
  • The rising demand for cell and gene therapies is creating new opportunities for the bio-banking market.

Market Dynamics

1. Drivers:

  • The need to develop new drugs and therapies is driving the demand for high-quality biological samples for research and development purposes.
  • The increasing prevalence of chronic diseases and genetic disorders is driving demand for biological samples for diagnosis and treatment.
  • Government initiatives to support biobanking and research programs are also driving the growth of the market.

2. Restraints:

  • The high cost associated with setting up and maintaining a biobank is a major restraint for the market.
  • Concerns over privacy and ethical issues related to the use of biological samples are also limiting the growth of the market.
  • Inadequate storage and transportation facilities, particularly in developing countries, is another restraint for the market.

3. Opportunities:

  • Emerging markets offer significant growth opportunities for the bio-banking market, particularly in Asia and the Middle East.
  • The development of new technologies, such as automation and cloud-based systems, is creating new opportunities for the market.
  • Collaborations and partnerships among biobanks and research institutions can lead to the development of new research and diagnostic tools.

4. Challenges

The bio-banking market faces several challenges that could impede its growth and development. One of the primary challenges is the lack of standardization and quality control across different biobanks and research institutions. Inconsistent sample collection, processing, and storage methods can lead to errors and inconsistencies in research data, which could have significant implications for patient care and scientific advancement.

Another challenge facing the bio-banking market is the management and sharing of data. The increasing amount of data generated by biobanks requires efficient data management and sharing systems, which must be interoperable and standardized to enable data integration and cross-institutional collaboration.

Interested to Procure the Data? Inquire here at  https://market.us/report/biobanking-market/#inquiry

Latest Developments

  • In April 2020, Fonds de recherche du Quebecand Genome Quebec together started Quebec COVID-19 biobank in Canada.
  • UK Biobank added data sets about measuring the range of circulation biomarkers to its database in March 2021.

Market Segmentation

Based on Product and Services

  • Equipment
  • Consumables
  • Software & Services

Based on the Sample Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Other Sample Types

Based on Application

  • Regenerative
  • Life Sciences
  • Other Applications

 Маrkеt Kеу Рlауеrѕ:

  • UK Biobank
  • IBBL
  • Shanghai Zhangjiang Biobank
  • Thermo Fisher Scientific Inc.
  • Isenet Biobanking
  • Brooks Life Sciences
  • Hamilton Company
  • ASKION
  • Other Key Players. 

Read Detailed Index of full Study at https://market.us/report/biobanking-market/

FAQ's:

1. What is the current size of the global biobanking market?

The global bio-banking market size is expected to be worth around USD 88.9 billion by 2032 from USD 48.9 billion in 2022, growing at a CAGR of 6.3% during the forecast period from 2022 to 2032

2. Which region is the largest market for biobanking?

North America is currently the largest market for biobanking, accounting for the majority of the global market share. This is primarily due to the presence of a large number of biobanks, advanced healthcare infrastructure, and increasing investments in research and development.

3. What are the major applications of biobanking?

The major applications of biobanking include Regenerative, Life Sciences, clinical diagnostics, and Other Applications. Biobanks provide researchers and clinicians with access to high-quality biological samples and associated data for a variety of research and clinical applications.

4. What are the key factors driving the growth of the biobanking market?

The key factors driving the growth of the biobanking market include increasing demand for personalized medicine, growing use of biomarkers in drug development, and rising investments in biobanking infrastructure. In addition, advances in technologies such as automation and artificial intelligence are also fueling growth in the biobanking industry.

Report Scope

Report Attribute

Details

The market size value in 2022

USD 48.09 Bn

Revenue forecast by 2032

USD 88.09 Bn

Growth Rate

CAGR Of 6.03%

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of the World

Historical Years

2017-2022

Base Year

2022

Estimated Year

2023

Short-Term Projection Year

2028

Long-Term Projected Year

2032

Contact us

Contact Person: Mr. Lawrence John

Market.us (Powered by Prudour Pvt. Ltd.)

Tel: +1 718 618 4351

Send Email: inquiry@market.us

For more information, please contact:

Author

Prudour Private Limited



Email:

Pramod@market.biz

Our
Latest
Publish

View all

May 15, 2024

Luxe Serena Skin Tag Remover Serum is a New Mole C...

May 14, 2024

YKSINOMAINEN! NexaSlim (Nexa Slim) Kokemuksia Suom...